Virax Biolabs Group Ltd
Diagnostics company · Lanarkshire, Scotland, United Kingdom · Nasdaq: VRAX
Virax Biolabs Group Ltd is a diagnostics company headquartered in Lanarkshire, Scotland, United Kingdom. Its earliest recorded incorporation is in 2021. Its shares trade on Nasdaq under the ticker VRAX. It has reported private securities offerings to the US SEC, most recently $5 million sold in a notice filed in 2025.
Virax Biolabs Group at a glance
What does Virax Biolabs Group do?
Private fundraising reported to the SEC
3 Form D notices; the most recent reported $5 million sold (2025).
Frequently asked questions about Virax Biolabs Group
Where is Virax Biolabs Group headquartered?
Virax Biolabs Group Ltd is headquartered in Lanarkshire, Scotland, United Kingdom.
What does Virax Biolabs Group do?
Virax Biolabs Group Ltd is a diagnostics company. Its SEC industry classification is In Vitro & In Vivo Diagnostic Substances.
Is Virax Biolabs Group a public company?
Yes. Virax Biolabs Group Ltd trades on Nasdaq under the ticker VRAX.
When was Virax Biolabs Group founded?
The earliest incorporation on record for Virax Biolabs Group Ltd is in 2021, according to public company registers.
Similar companies
- Oxford Immunotec Global PLCAbingdon, England, United Kingdom
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesLast updated 2026-09-25. Data licences